Scenic Biotech Enters Cooperative Research & Development Agreement with the National Institutes of Health for Genetic Modifier-Based Treatment Approach for Niemann-Pick Type C Disease : vimarsana.com

CRADA combines Scenic Biotech's genetic modifier platform with NIH's patient registry to unlock genetic modifiers as a path to novel therapies for Niemann-Pick Type C disease Scenic Biotech, a pioneer

Related Keywords

Sebastian Nijman , Oscar Izeboud , Eva Mulder Desmond James , Forbesd Porter , Human Development , Development Agreement , National Institutes Of Health , Trophic Communications , Scenic Biotech , Cooperative Research , Eunice Kennedy Shriver National Institute , Child Health , National Institutes , Senior Investigator , Mulder Desmond James , Profi Marcel Torney , Scenic , Iotech , Nters , Ooperative , Esearch , Evelopment , Greement , Ational , Nstitutes , Ealth , Enetic , Modifier , Ased , Reatment , Pproach , Niemann , Ick , Ype , Isease ,